Experience employing dosing regimens from once-a-day to four-times-a-day, as well as studies in primate epilepsy models involving constant rate infusion, indicate that total daily systemic bioavailability (extent of absorption) is the primary determinant of seizure control and that differences in the ratios of plasma peak to trough concentrations between valproate formulations are inconsequential from a practical clinical standpoint
At age 20, plasma concentrations average approximately 200 ng/mL
Infertility or pregnancy complications, including miscarriage, are also possible (Zimmermann 2012
T., Liu, H., Seano, G., Datta, M., Jones, D., Rahbari, N., et al
Additionally, these observations raise questions about the differences in GLP-1R activation in metastatic disease compared to primary disease